Milk Or Colostrum (e.g., Butter, Whey, Etc.) Patents (Class 424/535)
  • Patent number: 10881674
    Abstract: The invention relates to a method for stabilising or reducing insulin resistance in patients having an obesity-related, metabolic disorder, the method comprising administering to the patient an effective amount of one or more human milk oligosaccharides (HMOs).
    Type: Grant
    Filed: June 15, 2016
    Date of Patent: January 5, 2021
    Assignee: GLYCOM A/S
    Inventors: Bruce McConnell, Louise Kristine Vigsnæs, Emma Elison
  • Patent number: 10881705
    Abstract: Therapeutic compositions for addressing physiological stresses and aging include an immune modulator and one or more adaptogenic nutrients. Some non-limiting examples of immune modulators include as transfer factor, low molecular weight fraction immune modulators and/or other low molecular weight fractions of colostrum, egg or any other source of transfer factor or low molecular weight fraction immune modulators. Methods for administering immune modulators and adaptogenic nutrients to a subject to address the effects of physiological stresses and aging in the body of the subject, such as inflammatory responses, are also disclosed.
    Type: Grant
    Filed: July 9, 2019
    Date of Patent: January 5, 2021
    Assignee: 4Life Patents, LLC
    Inventor: Christopher M. Lockwood
  • Patent number: 10881639
    Abstract: The present invention relates to a composition of multivitamin vitamin B-C, particularly a composition of vitamin B-C for stimulating gastrointestinal (GI) system motility. The composition is suitable for preventing and/or treating conditions or diseases associated with insufficient GI motility.
    Type: Grant
    Filed: June 6, 2016
    Date of Patent: January 5, 2021
    Assignee: Zensun (Shanghai) Science & Technology, Co., Ltd.
    Inventor: Mingdong Zhou
  • Patent number: 10835544
    Abstract: The application relates to synthetic compositions containing one or more human milk oligosaccharides for regulating satiety or reducing propensity to obesity.
    Type: Grant
    Filed: June 15, 2016
    Date of Patent: November 17, 2020
    Assignee: GLYCOM A/S
    Inventors: Louise Kristine Vigsnæs, Bruce McConnell, Emma Elison
  • Patent number: 10828313
    Abstract: The invention relates to a synthetic composition comprising one or more human milk monosaccharides and/or one or more human milk oligosaccharides for use in reducing intestinal permeability, endotoxemia and/or low-grade inflammation in patients with metabolic disorders.
    Type: Grant
    Filed: December 8, 2015
    Date of Patent: November 10, 2020
    Assignee: GLYCOM A/S
    Inventors: Emma Salomonsson, Bruce McConnell, Thierry Hennet, Louise Kristine Vigsnæs
  • Patent number: 10702580
    Abstract: Improving the antioxidant capacity in an animal by increasing the level of glutathione in the blood or tissue of the animal comprising providing a composition containing beta-casein to the animal for consumption, where the beta-casein comprises at least 75% by weight of one or more beta-caseins not capable of producing beta-casomorphin-7 on enzymatic digestion. Uses include as an oxidant, for treating or preventing the symptoms of cancer, inflammation, kwashiorkor (protein deficiency), seizure, autism, Down's syndrome, chronic fatigue syndrome, Alzheimer's disease, Parkinson's disease, sickle cell anaemia, liver disease, cystic fibrosis, HIV, AIDS, infection, heart attack, stroke, and diabetes, avoiding or reducing the effects of aging, promoting the recovery of tissue following physical exercise, and promoting fertility.
    Type: Grant
    Filed: May 20, 2016
    Date of Patent: July 7, 2020
    Assignee: THE A2 MILK COMPANY LIMITED
    Inventors: Andrew John Clarke, Malav Suchin Trivedi
  • Patent number: 10568933
    Abstract: Regulating the level of glucose in the blood of an animal comprising the consumption by the animal of a composition containing beta-casein, or providing the composition to the animal for consumption, where the beta-casein comprises at least 75% by weight beta-casein A2. Uses include managing the symptoms of hyperglycaemia and associated conditions including diabetes. The effect is both acute (post-exposure to the composition) and ongoing.
    Type: Grant
    Filed: August 22, 2014
    Date of Patent: February 25, 2020
    Assignee: THE A2 MILK COMPANY LIMITED
    Inventors: Andrew John Clarke, Malav Suchin Trivedi
  • Patent number: 10500179
    Abstract: The invention relates to a free glycine source for use in inducing tolerance against an allergen, or preventing the development of allergy in a human or other mammal. The invention further relates to a composition comprising protein, fat and carbohydrates with at least 7 en % protein and at least 60 mg free glycine source per gram protein, preferably at least 70 mg glycine per gram protein. The free glycine source is preferably the free amino acid glycine, a salt of the free amino acid glycine, or a combination thereof; the protein can be intact protein, hydrolysed protein, peptides, free amino acids, salts of amino acids, or combinations thereof.
    Type: Grant
    Filed: September 30, 2016
    Date of Patent: December 10, 2019
    Assignee: N. V. Nutricia
    Inventor: Anita Hartog
  • Patent number: 10471100
    Abstract: Compositions that include extracts from sources of immune modulators that include nanofraction immune modulator molecules (i.e., molecules having molecular weights of about 3,000 Da and less) are disclosed. These compositions may also include other immune modulators, such as transfer factor. Administration of compositions with extracts that include nanofraction immune modulator molecules modulates the cell-mediated immunity (e.g., down-regulates undesired T cell activity) of a subject to which such compositions are administered. When administered with transfer factor, the combination of nanofraction immune modulator molecules and transfer factor down-regulates undesired T cell activity while increasing, or up-regulating, T cell activity against pathogens and other undesirable entities, such as cancer cells and other aberrant or mutated cells. Assays and assay techniques for evaluating the immune modulation capabilities of various substances are also disclosed.
    Type: Grant
    Filed: September 14, 2007
    Date of Patent: November 12, 2019
    Assignee: 4Life Patents, LLC
    Inventors: David A. Lisonbee, Calvin W. McCausland, Richard H. Bennett, Brent M. Vaughan, Shane M. Lefler
  • Patent number: 10465148
    Abstract: Methods and systems to manufacture a soap bar comprising post-brew coffee particles are disclosed. A soap bar may comprise multiple post-brew coffee ground particle sizes to take advantage of the benefits associated with each size. For example, the soap bar may comprise espresso grinds (0.20 mm), regular grinds (1.0 mm), and/or coarse grinds (1.5 mm). A saponified fat base, e.g., a milk soap base, a plant oil base, and/or an animal fat base may be obtained and heated to a consistency. Collected post-brew coffee grounds may then be added. The coffee grounds may be anywhere from 1% to 65% of the total weight of the final product, depending on the desired soap quality. The final soap product may comprise coffee ground positive and coffee ground negative layers or portion, or the coffee grounds may be evenly dispersed throughout the product.
    Type: Grant
    Filed: May 25, 2017
    Date of Patent: November 5, 2019
    Inventor: Mark Guerino
  • Patent number: 10380328
    Abstract: A method includes obtaining training data for a plurality of patients of a patient population. The training data includes training blood glucose history data including treatment doses of insulin administered by the patients of the patient population and one or more outcome attributes associated with each treatment dose. The method also includes identifying, for each patient of the patient population, one or more optimum treatment doses of insulin from the treatment doses yielding favorable outcome attributes. The method also includes receiving patient-state information for the treated patient, determining a next recommended treatment dose of insulin for the treated patient based on one or more of the identified optimum treatment doses associated with the patients of the patient population having training patient-state information similar to the patient-state information for the treated patient, and transmitting the next recommended treatment dose to a portable device associated with the treated patient.
    Type: Grant
    Filed: December 21, 2017
    Date of Patent: August 13, 2019
    Assignee: Aseko, Inc.
    Inventors: Robert C. Booth, Harry Hebblewhite
  • Patent number: 10278404
    Abstract: The present invention relates to a novel composition with milk of immunized camelid, particularly, (Camelus dromedarius) as the main component (i.e. active ingredient) and a method for the treatment or prevention of gastrointestinal infections, particularly, infections caused by Escherichia coli (E. coli), Helicobacter Pylori (H. pylori), Campylobacter jejuni (C. jejuni), Salmonella enterica, Shigella dysenteriae, Clostridium perfringens, or Yersinia enterocolitica. Said composition is prepared in the form of pharmaceutical, nutraceutical, or health food preparations. The present invention also discloses a process of preparing said composition.
    Type: Grant
    Filed: September 11, 2012
    Date of Patent: May 7, 2019
    Assignee: AL-URDONIA LEMUDADDAT AL-AJSAM CO
    Inventors: Khaled Mahmood Al-Qaoud, Penelope Agmad Shihab, Luay Fawzi Abu-Oatousch, Christopher R. Lowe
  • Patent number: 10190142
    Abstract: Provided is a method of preparing a high-purity galactooligosaccharide composition by fermentation of a low-purity galactooligosaccharide mixture with a yeast strain, Kluyveromyces lactis ATCC 8585. The high-purity galactooligosaccharide composition includes at least 99% of galactooligosaccharides selected from the group consisting of galactotriose, galactotetrose, galactooligosaccharides with five or more sugar units, and combinations thereof and lower than 1% of monosaccharides and disaccharides. Also provided is a high-purity galactooligosaccharide composition and applications thereof in regulating blood glucose level and improving gut microbiota. For example, the high-purity galactooligosaccharide composition may be used to manufacture food products, beverages, health food products, nutritional supplements, and pharmaceutical compositions for patients or pets afflicted with diabetes mellitus or lactose intolerance.
    Type: Grant
    Filed: January 5, 2017
    Date of Patent: January 29, 2019
    Assignee: KING-PREBIOTICS BIOTECHNOLOGY (TW) CO., LTD.
    Inventors: Chang-Lung Tsai, Ping-Ju Tsai
  • Patent number: 9999643
    Abstract: A therapeutic composition for wet and dry gangrene includes an herbal composition alone, or in combination with one or more animal-derived products. The herbal composition can include a mixture of Saussurea acrophila Diels, Saussurea ceratocarpa, and Aucklandia lappa Decne. The mixture can include, for example, a mixture of extracts or whole herbs of Saussurea acrophila Diels, Saussurea ceratocarpa, and Aucklandia lappa Decne. The one or more animal-derived products can include at least one of camel milk and camel saliva.
    Type: Grant
    Filed: October 16, 2017
    Date of Patent: June 19, 2018
    Assignee: SULTAN QABOOS UNIVERISTY
    Inventors: Sidgi Syed Anwer Abdo Hasson, Ali A. H. Al-Jabri
  • Patent number: 9750775
    Abstract: The present invention provides very safe lactic acid bacteria and lactic acid bacteria preparations which are effective in prevention and therapy of allergies and/or in lowering of the blood neutral fat level. The present invention also provides pharmaceutical products and food or drink products which contain, as an active ingredient, a composition that contains cultured cells of the lactic acid bacterium Pediococcus acidilactici R037 or a treated product thereof.
    Type: Grant
    Filed: May 8, 2015
    Date of Patent: September 5, 2017
    Assignee: Kaneka Corporation
    Inventors: Airo Tategaki, Toyoaki Watanabe, Kazuya Hamada
  • Patent number: 9707199
    Abstract: Methods for detecting risks for and/or causes of metabolic syndrome or hyperferritinemia in accordance with several embodiments can include the step of measuring the level of heptadecanoic acid in a blood sample of a subject. The methods of several embodiments can further include the step of deeming the subject as having or being at risk of metabolic syndrome if the amount of heptadecanoic acid is below 0.4% of all fatty acids in the sera or plasma. The methods for treating metabolic syndrome or hyperferritinemia according to several embodiments can also include the step of administering a daily dose of heptadecanoic acid to a subject suffering from metabolic syndrome or hyperferritinemia for a period of time from three weeks to twenty-four weeks, wherein the minimum daily dose comprises about 3 mg per lb (or 6 mg per kg) of body weight.
    Type: Grant
    Filed: December 28, 2015
    Date of Patent: July 18, 2017
    Assignee: The United States of America, as Represented by the Secretary of the Navy
    Inventor: Stephanie Venn-Watson
  • Patent number: 9675650
    Abstract: The present invention relates to a composition for removing keratinous skin material, the composition comprising a Lactobacillus strain or a culture thereof. Also, the present invention relates to a composition for removing keratinous skin material, the composition comprising green tea Lactobacillus as Lactobacillus. In contrast to when skin is improved through the supply of a moisture fraction by a commonly used skin-moisturizing component, the Lactobacillus according to the present invention removes keratinous skin material, thereby producing the advantageous effect that skin can be cared for and improved as the waste materials which accumulates on the skin is fundamentally removed. Therefore, the composition according to the present invention can effectively prevent or alleviate skin problems such as spots. Also, the invention regulates the skin and so improves skin tone by removing surplus keratinous material which is not needed by the skin.
    Type: Grant
    Filed: October 29, 2013
    Date of Patent: June 13, 2017
    Assignee: AMOREPACIFIC CORPORATION
    Inventors: Joon Ho Park, Yeon Ju Hong, Il Young Kwack, Jong Won Shim, Jin Sup Shim, Kyeong Hwan Hwang, Young Gyu Kang, Myeong Hun Yeom, Jun Cheol Cho
  • Patent number: 9480717
    Abstract: The invention relates to the production of compositions containing milk products for use as a nutritional supplement. More specifically, it relates to compositions containing whey growth factor extract, as well as their use in methods for reducing muscle inflammation in individuals undertaking resistance exercise training. According to one aspect of the invention, there is provided the use of a composition comprising whey growth factor extract, isolated from a milk product by cation exchange chromatography, to reduce exercise-induced muscle inflammation.
    Type: Grant
    Filed: September 4, 2012
    Date of Patent: November 1, 2016
    Assignee: Murray Goulburn Co-Operative Co Limited
    Inventors: Michelle Rowney, David Cameron-Smith
  • Patent number: 9180168
    Abstract: Methods for improving the health of a female human or non-human animal are disclosed. The methods include the step of administering to the animal compositions including an effective amount of glycomacropeptide (GMP) for effectuating the methods. Specifically, the methods can be used to increase the rate of fat metabolism or fat oxidation, decrease percentage of body fat, increase the rate of bone mineralization, increase bone mineral content, increase bone mineral density, and/or increase bone strength in the animal. GMP-containing compositions can be used according to the disclosed methods to treat obesity and related metabolic conditions, or to treat or prevent osteoporosis, osteopenia, and other conditions related to loss of bone mineral content or bone strength.
    Type: Grant
    Filed: January 31, 2013
    Date of Patent: November 10, 2015
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Denise M. Ney, Eric Chi-Liang Yen, David W. Nelson, Patrick Solverson
  • Patent number: 9107894
    Abstract: The subject invention provides compositions, and uses thereof, that improve gastrointestinal function. The compositions and methods of the subject invention are particularly advantageous for use with neonates because they can be used to stimulate development of the immature intestine in order to provide an enhanced ability to absorb nutrients and attain a stronger barrier function.
    Type: Grant
    Filed: October 14, 2008
    Date of Patent: August 18, 2015
    Assignee: University of Florida Research Foundation, Inc.
    Inventor: Josef Neu
  • Patent number: 9095570
    Abstract: The present invention relates generally to the field of neuronal health and neuronal protection. One embodiment of the present invention relates to a composition that can be used for the protection of the enteric nervous system from neurodegeneration. Disorders linked to an impaired enteric nervous system can be treated or prevented by the administration of lactoferrin containing compositions according to the present invention.
    Type: Grant
    Filed: November 6, 2013
    Date of Patent: August 4, 2015
    Assignee: Nestec S.A.
    Inventors: Magali Faure, Bing Wang, Jeroen Schmitt
  • Publication number: 20150104523
    Abstract: Therapeutic compositions for addressing physiological stresses and aging include an immune modulator and one or more adaptogenic nutrients. Some non-limiting examples of immune modulators include as transfer factor, low molecular weight fraction immune modulators and/or other low molecular weight fractions of colostrum, egg or any other source of transfer factor or low molecular weight fraction immune modulators. Methods for administering immune modulators and adaptogenic nutrients to a subject to address the effects of physiological stresses and aging in the body of the subject, such as inflammatory responses, are also disclosed.
    Type: Application
    Filed: October 13, 2014
    Publication date: April 16, 2015
    Inventor: Christopher M. Lockwood
  • Publication number: 20150093446
    Abstract: An exfoliating body scrub composition is made from natural ingredients. The body scrub composition comprises ground coffee; ground whole oats; dry milk; from about 0.5% by weight to about 5% by weight of soy flour, based on the total weight of the coffee; oats; dry milk; and soy flour. The body scrub composition further comprises an optional carrier, such as an aqueous carrier, a moisturizing nonaqueous carrier, or a solid carrier. The body scrub composition may be made by combining solid ingredients comprising ground coffee, ground whole oats, dry milk, and from about 0.5% by weight to about 5% by weight of soy flour; and mixing the solid ingredients to produce a uniform powdered mixture. The uniform powdered mixture is optionally mixed with a carrier.
    Type: Application
    Filed: October 1, 2013
    Publication date: April 2, 2015
    Inventor: Aleksandra Muller
  • Patent number: 8987196
    Abstract: The present invention concerns an improved balance of the essential branched chain amino acids leucine, isoleucine and valine in infant formula.
    Type: Grant
    Filed: March 25, 2011
    Date of Patent: March 24, 2015
    Assignee: N.V. Nutricia
    Inventors: Johannes Bernard Van Goudoever, Eline Marleen Van Der Beek, Marieke Abrahamse-Berkeveld, Günther Boehm
  • Publication number: 20150079195
    Abstract: This medicine is used treat Cancer, Pain and Bipolar. It can be taken as food or as a potent medicine in therapeutic effective amounts and potencies. It treats Cancer, depression, psychosis, manic symptoms, fear, Attention deficit symptoms, illness symptoms, pain, right lip retardation and removes bumps on the necks within a week or two. It is interchangeable in the ingredients. It can be combined with Pharmaceutical drugs and ingredients. It decreases the need for narcotics, cancer drugs or mental health drugs. It is extremely strong or potent and can be made weak or make your little ADD or Bipolar kid normal. It just has a continual ability. It is very potent.
    Type: Application
    Filed: September 17, 2013
    Publication date: March 19, 2015
    Applicant: Children's Fund
    Inventor: Diane Elizabeth Brooks
  • Patent number: 8974832
    Abstract: A nutritional product composition for increasing human growth hormone and nitric oxide production, to increase lean muscle mass, decrease body fat, and improve cardiovascular function and immune function. The nutritional product composition includes a synergistic blend of nutrients and a silica gel that increases the rate of metabolism of cells to increase the rate of absorption of the nutrients and elevate the production of the human growth hormone and elevate nitric oxide production. The synergistic blend of nutrients includes colostrum, L-arginine, potassium citrate and goji berry extract. The silica gel increases an absorption rate of the synergistic blend.
    Type: Grant
    Filed: December 10, 2013
    Date of Patent: March 10, 2015
    Assignee: Lifewave, Inc.
    Inventors: David Schmidt, Steve Haltiwanger
  • Publication number: 20150064271
    Abstract: New Lactococcus lactis strains, NRRL B-50571 and NRRL B-50572, and a bacterial preparation containing the same, have the ability to produce bioactive peptides that reduce blood pressure, lower LDL-cholesterol (bad cholesterol) and present antioxidant properties for better cardiovascular health. These biologically active peptides may be produced within the food for the production of a food product, such as a functional food, or they may be produced from protein sources and subsequently added to a food as part of the formulation or as part of a food supplement or a pharmaceutical preparation.
    Type: Application
    Filed: October 8, 2014
    Publication date: March 5, 2015
    Inventors: Belinda Vallejo Galland, Aarón Fernando González Córdova, Jóse Carlos Rodríguez Figueroa
  • Publication number: 20150050320
    Abstract: A composition for diet supplementation to improve gut microflora is disclosed. The composition includes a prebiotic source and source of nucleotides, such as an extract of yeast. Also disclosed are methods of diet supplementation that include administering compositions of the invention to an individual.
    Type: Application
    Filed: August 15, 2014
    Publication date: February 19, 2015
    Inventor: Mark G. CONNELL
  • Publication number: 20150030687
    Abstract: The use of a fermented milk product comprising non-hydrolysed whey proteins which is substantially free of casein proteins for the purpose of improving skin firmness, by structuring collagen without promoting collagen synthesis, when topically applied to skin is provided.
    Type: Application
    Filed: October 13, 2014
    Publication date: January 29, 2015
    Inventors: Severine LlEUREY, Stephen WATKINS
  • Patent number: 8927027
    Abstract: This disclosure features human milk permeates and compositions containing the same obtained from fractionated whole human milk. The oligosaccharide rich permeate and permeate compositions of the present invention are useful as nutritional supplements for pre-term and full term infants, for establishing or maintaining gut flora and for treating the symptoms of inflammatory bowel disease.
    Type: Grant
    Filed: December 2, 2009
    Date of Patent: January 6, 2015
    Assignee: Prolacta Bioscience
    Inventors: Joseph Fournell, Scott Eaker, Scott Elster, David J. Rechtman
  • Publication number: 20150004246
    Abstract: This invention relates to a formulation for the treatment of diabetes including 56 mg to 224 mg cow urine powder and 44 mg to 176 mg skim milk powder per kg body weight of the patient.
    Type: Application
    Filed: June 26, 2014
    Publication date: January 1, 2015
    Inventors: Yashwant Atbhaiya, Preetam Lal Choudhary
  • Publication number: 20140342010
    Abstract: The present invention provides a method of using Polygonum multiflorum or extracts thereof to enhance stem cell mobilization in a subject, including hematopoietic stem cells (HSCs) and bone marrow stem cells (BM-SCs). In one embodiment, a blended composition of plant parts, fruits, mushrooms, microorganisms, maternal fluids, and extracts thereof are used to promote mobilization of stem cells, resulting in migration of the stem cells to specific sties of maintenance and repair within tissues and/or organs. Increased circulation of HSCs and/or BMSCs and migration towards sites of maintenance promotes the natural regeneration mechanisms in the body.
    Type: Application
    Filed: November 15, 2012
    Publication date: November 20, 2014
    Applicant: Stemtech International, Inc.
    Inventors: Christian Drapeau, Gitte S. Jensen
  • Publication number: 20140335196
    Abstract: The present invention relates to fungicidal compositions and particularly fungicidal compositions comprising anhydrous milk fat (AMF), soybean oil and/or coconut fat. The invention also relates to a fungicidal method employing a composition of the invention. The compositions and methods of the invention have applications in the management (prevention and control) of fungal growth in commercial and small scale crop production.
    Type: Application
    Filed: April 29, 2014
    Publication date: November 13, 2014
    Applicant: THE NEW ZEALAND INSTITUTE FOR PLANT AND FOOD RESEARCH LIMITED
    Inventors: Kirstin Verity WURMS, Annette Ah Chee
  • Publication number: 20140328938
    Abstract: Biodegradable pharmaceutical compositions comprising 1,3-propanediol and its esters are provided. The 1,3-propanediol and its esters in the pharmaceutical composition are biologically derived, and as such, the pharmaceutical compositions exhibit a low anthropogenic CO2 emission profile.
    Type: Application
    Filed: July 14, 2014
    Publication date: November 6, 2014
    Applicant: DuPont Tate & Lyle Bio Products Company, LLC
    Inventors: Robert Miller, Joseph Desalvo, Gyorgyi Fenyvesi, Melissa Joerger, Raja Hari Poladi, Ann Wehner
  • Publication number: 20140322329
    Abstract: The present invention relates to topical vaginal compositions in gel form containing immune mediators, growth factors, chemotactic factors and antibacterial/antiviral factors extracted from bovine colostrum, and optionally other ingredients with complementary activity.
    Type: Application
    Filed: December 2, 2011
    Publication date: October 30, 2014
    Applicant: ZAMBON S.P.A.
    Inventors: Alberto Bartorelli, Maria Rosa Gobbi
  • Patent number: 8858988
    Abstract: Compositions for the treatment of sores, wounds, burns and other traumatized dermal tissues and skin injuries comprising Boswellia gum, gel, resin or extract, Tea Tree oil (Melaleuca oil), an Aloe gel, resin, latex or extract and Lavender oil. The composition may be incorporated into a medical device such as a wound dressing or bandage, or formulated into a topical preparation such as an ointment, lotion or cream.
    Type: Grant
    Filed: November 2, 2010
    Date of Patent: October 14, 2014
    Assignees: CuraPhyte Technologies Inc., Nutriquine N.V.
    Inventors: Guy Chamberland, Peter Bollen
  • Publication number: 20140287056
    Abstract: The invention relates to whey protein micelles for use in the treatment and/or prevention of a disorder linked to an increase in insulin secretion and/or plasma IGF-1 concentration in an infant at risk of developing obesity or diabetes. The invention also relates to a nutritional composition for infants comprising whey protein micelles. Further, the invention relates to a non-therapeutic use of a nutritional composition for infants, comprising whey protein micelles.
    Type: Application
    Filed: October 19, 2012
    Publication date: September 25, 2014
    Inventors: Catherine Mace, Lionel Jean Rene Bovetto, Etienne Pouteau
  • Publication number: 20140287057
    Abstract: A dietary product for preventing cardiometabolic risk in humans, in particular for reducing visceral fat and deep subcutaneous fat, includes in particular a mixture of: a whey hydrolysate having a molecular weight of between 200 and 10,000 daltons, an isolate and/or concentrate of whey, and calcium caseinate.
    Type: Application
    Filed: October 25, 2012
    Publication date: September 25, 2014
    Inventor: Claude Vincent
  • Publication number: 20140248370
    Abstract: An enhancement composition includes a combination of natural ingredients that form a synergy to enhance the health, appearance, smell, and psyche of a surface, such as skin. Unnatural or processed ingredients are not included that can cause irritation and more detrimental effects to the skin. The enhancement composition has no preservatives because the particular combination of elements in the cream disclosed herein preserves the cream and permits a long shelf life. The enhancement composition is fabricated by combining, mixing, and sometimes heating predetermined amounts of Frankincense, Myrrh, black seed, and aloe. Additional ingredients can include, Shea butter, camel hump butter, coconut oil, olive oil, ginseng, natural resins, fatty acids, and various oils. The ingredients are combined by mixing, heating, cooling, distilling, or applying radiation. The composition promotes of spiritual health, particularly when implemented to include Frankincense and Myrrh.
    Type: Application
    Filed: March 4, 2014
    Publication date: September 4, 2014
    Inventor: Abdulkadir Hashi Ali
  • Patent number: 8821878
    Abstract: The disclosure features methods of making compositions that include a human lipid. The methods can include: obtaining whole human milk; separating the milk into a cream portion and a skim portion; processing the cream portion; and pasteurizing the processed cream portion.
    Type: Grant
    Filed: January 14, 2013
    Date of Patent: September 2, 2014
    Assignee: Prolacta Bioscience, Inc.
    Inventors: Elena M. Medo, Scott Eaker
  • Publication number: 20140242182
    Abstract: In one aspect, the disclosure provides formulations that stabilize proteins, wherein the formulations comprise a buffer. In some embodiments, the buffer comprises potassium mono-hydrogen-phosphate and potassium di-hydrogen-phosphate, or the buffer comprises sodium mono-hydrogen-phosphate and sodium di-hydrogen-phosphate. In some embodiments, the protein is a therapeutic protein. In some embodiments, the therapeutic protein is antithrombin.
    Type: Application
    Filed: July 6, 2012
    Publication date: August 28, 2014
    Applicant: rEVO Biologics, Inc
    Inventors: Sean A. Evans, Greg J. Allard, Nicholas C. Masiello
  • Publication number: 20140234433
    Abstract: The invention provides topical compositions including vitamin A, colostrum (or extracts of colostrum with a high IGF content) with or without avian eggshell membrane, that stimulate the epidermis and dermis layers of the skin to treat skin aging.
    Type: Application
    Filed: February 14, 2014
    Publication date: August 21, 2014
    Inventors: Nicholas V. Perricone, Peter T. Pugliese
  • Publication number: 20140227363
    Abstract: Described herein are various natural ingredients for skin-related applications. Individual compounds provide beneficial effects for improved collagen production, fibroblast proliferation, antioxidant protection and free radical inhibition. Combinations of these individual compounds exhibit synergistic effects, leading to dramatic improvements in skin moisture levels, wrinkle reduction, and elasticity. Various examples of combined ingredients are provided, which can be applied in methods related to conditioning the skin, and in cosmetic formulations for improved aesthetic appearance.
    Type: Application
    Filed: August 3, 2012
    Publication date: August 14, 2014
    Applicant: STEMTECH INTERNATIONAL, INC.
    Inventors: Christian Drapeau, Shakahn Kukulcan, Gitte S. Jensen
  • Patent number: 8778404
    Abstract: The present inventors discovered that the onset of galactosamine hepatopathy is suppressed by nutritional compositions comprising as essential ingredients: whey protein hydrolysates; lecithin and oils and fats high in oleic acid, which are able to improve the lipid metabolism; and palatinose having an insulin-sparing effect. Furthermore, the whey protein hydrolysate included in the nutritional compositions was found to suppress endotoxin-induced TNF-a and interleukin 6 (IL-6) production in macrophages.
    Type: Grant
    Filed: May 30, 2009
    Date of Patent: July 15, 2014
    Assignee: Meiji Co., Ltd.
    Inventors: Hisae Kume, Makoto Yamaguchi, Kenji Mizumoto, Hajime Sasaki
  • Publication number: 20140186456
    Abstract: The inventive tripartite composition is a combination of fucoidan, trans-resveratrol, and bovine colostrum in effective quantities, in the range of from 1:1.5:1.5 to 1:10:10 in weight percent. This composition provides antioxidant protection of cells against free radicals, strengthens the immune system, and enhances cellular function and stem cell population, thereby providing renewal and repair throughout the body. The inventive composition can be administered by capsules, but is preferably applied in liquid form to the oral cavity, such as by sublingual dropper or by intraoral spray. This sublingual, intraoral application method of administration provides maximum absorption, thus minimizing cost, avoiding inactive ingredients that are present in tablets and capsules, increasing consumer convenience, acid eliminating stomach irritation.
    Type: Application
    Filed: August 25, 2012
    Publication date: July 3, 2014
    Inventors: Lillian M. Day, Tony A. Sampson
  • Publication number: 20140147488
    Abstract: The present invention relates to a feed or food product composition which comprises a mixture of bovine colostrum, comprising bioactive components, and organic particulate matter having a size between 0.3 and 7 mm in diameter. The composition is especially adapted to deliver the mixture of bioactive bovine colostrum components to the digestive tract of a mammal.
    Type: Application
    Filed: April 8, 2013
    Publication date: May 29, 2014
    Applicant: ColoPlus AB
    Inventor: ColoPlus AB
  • Patent number: 8728539
    Abstract: Disclosed is a method of enhancing absorption (pinocytosis efficiecy) of immunoglobulins administered to postnatal domestic mammals (e.g., bovine) by using selenium. As an example of a selenium compound added, sodium selenite is particularly effective.
    Type: Grant
    Filed: May 12, 2008
    Date of Patent: May 20, 2014
    Assignee: Incorporated Administrative Agency, National Agriculture and Bio-Oriented Research Organization
    Inventors: Hachiro Kamada, Itoko Nonaka
  • Patent number: 8722098
    Abstract: A method of alleviating or preventing inflammation in an animal is provided. In concrete, the method comprises the step of administering to an animal a composition including an Ecklonia cava extract in an amount effective to suppress SOCS-3 expression in the animal to thereby alleviate or prevent inflammation in the animal.
    Type: Grant
    Filed: September 6, 2007
    Date of Patent: May 13, 2014
    Assignee: Pukyong National University Industry-Academic Cooperation
    Inventors: Il-Whan Choi, Da-Young Lee, Inhak Choi, Se-Kwon Kim, Won-Kyo Jung, Sung Su Yea, Yung Hyun Choi
  • Publication number: 20140120173
    Abstract: The present invention discloses a novel milk-fermented product comprising a group of peptides. The peptides are composed from no. 1 to no. 7 of the figure that is selected from the group consisting of FIG. 11 to FIG. 18. And the novel milk-fermented product is used for suppressing the reduction of bone mineral density. Therefore, the novel milk-fermented product could be a component of foods, nutrient supplement or medicine for treating or preventing osteoporosis.
    Type: Application
    Filed: October 26, 2012
    Publication date: May 1, 2014
    Applicant: National Chung Hsing University
    Inventors: Chuan-Mu Chen, Hsiao-Ling Chen
  • Patent number: 8710003
    Abstract: A milk protein hydrolysate which is preferably caseinoglycomacropeptide and/or a whey protein in a bioavailable form is used for the manufacture of a composition for the treatment or prevention of diabetes or syndrome X. The invention also relates to a method of treatment or prevention of diabetes or syndrome X utilizing such compositions, a method for assessing proglucagon gene expression and GLP-1 release by a cell line derived from an adenocarcinoma of human caecum.
    Type: Grant
    Filed: May 18, 2010
    Date of Patent: April 29, 2014
    Assignee: Nestec S.A.
    Inventors: Raylene Alison Reimer, Christian Darimont-Nicolau, Katherine Mace, Sandrine Gremlich, Jean-Richard Neeser